Australia markets closed

Sansure Biotech Inc. (688289.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
20.82+0.36 (+1.76%)
At close: 03:00PM CST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
384,733
363,721
1,936,801
2,242,696
2,616,597
Depreciation & amortisation
22,445
116,896
89,074
53,941
26,684
Change in working capital
-
-81,926
203,319
-402,129
-50,381
Inventory
-
-78,297
-282,103
-93,035
-212,072
Other working capital
-299,261
-347,810
2,000,119
1,504,207
2,533,611
Other non-cash items
-
17,966
20,453
41,214
47,815
Net cash provided by operating activities
-
43,540
2,558,947
1,877,071
2,642,276
Cash flows from investing activities
Investments in property, plant and equipment
-335,039
-391,350
-558,828
-372,864
-108,666
Acquisitions, net
-
-112,998
-11,591
-
-
Purchases of investments
-6,118,595
-7,434,262
-12,140,550
-7,879,952
-3,725,000
Sales/maturities of investments
8,261,289
9,294,932
11,591,092
7,125,563
2,111,334
Other investing activities
-2,226
40,748
-46,875
-909.3035
-108,666
Net cash used for investing activities
1,736,153
1,397,790
-1,166,746
-1,112,221
-1,715,957
Net change in cash
1,827,440
1,072,564
466,244
42,006
2,491,634
Cash at beginning of period
2,429,545
3,099,050
2,632,806
2,590,800
99,166
Cash at end of period
4,257,942
4,171,614
3,099,050
2,632,806
2,590,800
Free cash flow
Operating cash flow
-
43,540
2,558,947
1,877,071
2,642,276
Capital expenditure
-335,039
-391,350
-558,828
-372,864
-108,666
Free cash flow
-299,261
-347,810
2,000,119
1,504,207
2,533,611